Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphaèle Seror

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Rheumatic Diseases Clinics of North America|November 29, 2016
Malignancy and the Risks of Biologic Therapies: Current StatusRaphaèle Seror, Xavier Mariette
Joint Bone Spine|February 26, 2023
Cancer screening in chronic inflammatory rheumatic diseasesJoanna Kedra, Raphaèle Seror
Presse Medicale (Paris, France : 1983)|July 31, 2012
[Beautification of data: Minimal fraud, incompetence or mixture of both]Raphaèle Seror, Philippe Ravaud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 15, 2007
Plasma exchange for rheumatoid arthritisRaphaèle Seror, Christian Pagnoux, Loïc Guillevin
Nature Reviews. Rheumatology|June 30, 2021
Current and future therapies for primary Sjögren syndromeRaphaèle Seror, Gaetane Nocturne, Xavier Mariette
Current Opinion in Immunology|February 19, 2026
Evolution and prospects for the definition of clinically useful endpoints in Sjögren diseaseMaxime Beydon, Simon J Bowman, Raphaèle Seror
BMJ (Clinical Research Ed.)|July 3, 2013
Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic reviewAïda Bafeta, Ludovic Trinquart, Raphaèle Seror, et al.
BMJ (Clinical Research Ed.)|March 13, 2014
Reporting of results from network meta-analyses: methodological systematic reviewAïda Bafeta, Ludovic Trinquart, Raphaèle Seror, et al.
Joint Bone Spine|March 27, 2021
Inflammation-targeted therapies and cancerJoanna Kedra, Gaetane Nocturne, Xavier Mariette, et al.
Best Practice & Research. Clinical Rheumatology|April 25, 2016
New biological therapies in Sjögren's syndromeGaetane Nocturne, Divi Cornec, Raphaèle Seror, et al.
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Rheumatic Diseases Clinics of North America|November 29, 2016
Malignancy and the Risks of Biologic Therapies: Current StatusRaphaèle Seror, Xavier Mariette
Joint Bone Spine|February 26, 2023
Cancer screening in chronic inflammatory rheumatic diseasesJoanna Kedra, Raphaèle Seror
Presse Medicale (Paris, France : 1983)|July 31, 2012
[Beautification of data: Minimal fraud, incompetence or mixture of both]Raphaèle Seror, Philippe Ravaud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 15, 2007
Plasma exchange for rheumatoid arthritisRaphaèle Seror, Christian Pagnoux, Loïc Guillevin
Nature Reviews. Rheumatology|June 30, 2021
Current and future therapies for primary Sjögren syndromeRaphaèle Seror, Gaetane Nocturne, Xavier Mariette
Current Opinion in Immunology|February 19, 2026
Evolution and prospects for the definition of clinically useful endpoints in Sjögren diseaseMaxime Beydon, Simon J Bowman, Raphaèle Seror
BMJ (Clinical Research Ed.)|July 3, 2013
Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic reviewAïda Bafeta, Ludovic Trinquart, Raphaèle Seror, et al.
BMJ (Clinical Research Ed.)|March 13, 2014
Reporting of results from network meta-analyses: methodological systematic reviewAïda Bafeta, Ludovic Trinquart, Raphaèle Seror, et al.
Joint Bone Spine|March 27, 2021
Inflammation-targeted therapies and cancerJoanna Kedra, Gaetane Nocturne, Xavier Mariette, et al.
Best Practice & Research. Clinical Rheumatology|April 25, 2016
New biological therapies in Sjögren's syndromeGaetane Nocturne, Divi Cornec, Raphaèle Seror, et al.
Pageof 14